Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review.

Falagas ME, Siempos II, Bliziotis IA, Panos GZ.

Mayo Clin Proc. 2006 Dec;81(12):1567-74. Review.

PMID:
17165635
2.

The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.

Falagas ME, Matthaiou DK, Bliziotis IA.

J Antimicrob Chemother. 2006 Apr;57(4):639-47. Epub 2006 Feb 24. Review.

PMID:
16501057
3.

Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study.

Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR.

Clin Microbiol Infect. 2013 Mar;19(3):257-64. doi: 10.1111/j.1469-0691.2012.03783.x. Epub 2012 Mar 8.

4.

Severe pneumococcal pneumonia: impact of new quinolones on prognosis.

Olive D, Georges H, Devos P, Boussekey N, Chiche A, Meybeck A, Alfandari S, Leroy O.

BMC Infect Dis. 2011 Mar 15;11:66. doi: 10.1186/1471-2334-11-66.

5.

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.

Lujan M, Gallego M, Fontanals D, Mariscal D, Rello J.

Crit Care Med. 2004 Mar;32(3):625-31.

PMID:
15090938
6.

Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.

Fernández Guerrero ML, Ramos JM, Marrero J, Cuenca M, Fernández Roblas R, de Górgolas M.

Int J Infect Dis. 2003 Mar;7(1):46-52.

PMID:
12718810
7.

Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Garau J.

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):83-99. Review.

PMID:
15696306
8.

Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?

Falcó V, Almirante B, Jordano Q, Calonge L, del Valle O, Pigrau C, Planes AM, Gavaldà J, Pahissa A.

J Antimicrob Chemother. 2004 Aug;54(2):481-8. Epub 2004 Jun 23.

PMID:
15215226
10.

Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.

Waterer GW, Somes GW, Wunderink RG.

Arch Intern Med. 2001 Aug 13-27;161(15):1837-42.

PMID:
11493124
11.

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J.

Clin Infect Dis. 2003 Feb 15;36(4):389-95. Epub 2003 Jan 31.

PMID:
12567294
12.

Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.

Padrones S, Garcia-Vidal C, Fernández-Serrano S, Fernández A, Masuet C, Carratalà J, Coromines M, Ardanuy C, Gudiol F, Manresa F, Dorca J.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1243-51. doi: 10.1007/s10096-010-0993-0. Epub 2010 Jun 22.

PMID:
20567869
13.

β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.

Nie W, Li B, Xiu Q.

J Antimicrob Chemother. 2014 Jun;69(6):1441-6. doi: 10.1093/jac/dku033. Epub 2014 Feb 16. Review.

PMID:
24535276
14.

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.

Bliziotis IA, Samonis G, Vardakas KZ, Chrysanthopoulou S, Falagas ME.

Clin Infect Dis. 2005 Jul 15;41(2):149-58. Epub 2005 May 31.

PMID:
15983909
15.

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.

Paul M, Soares-Weiser K, Grozinsky S, Leibovici L.

Cochrane Database Syst Rev. 2003;(3):CD003038. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD003038.

PMID:
12917941
16.
17.

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.

Paul M, Soares-Weiser K, Grozinsky S, Leibovici L.

Cochrane Database Syst Rev. 2002;(2):CD003038. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003038.

PMID:
12076467
18.

Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.

Bliziotis IA, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME.

Mayo Clin Proc. 2005 Sep;80(9):1146-56.

PMID:
16178494
19.

Short-course beta-lactam treatment for community-acquired pneumonia.

Stralin K, Sjöberg L, Holmberg H.

Clin Infect Dis. 2004 Mar 1;38(5):766-7. No abstract available.

PMID:
14986269
20.

The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis.

Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM.

Clin Infect Dis. 2006 Mar 15;42(6):788-97. Epub 2006 Feb 8. Review.

PMID:
16477555

Supplemental Content

Support Center